Vaultinum est mandaté par Eurazeo pour réaliser un Audit Cyber et Tech
29 mars 2023 08h30 HE
|
Vaultinum
PARIS, 29 mars 2023 (GLOBE NEWSWIRE) -- Eurazeo mandate la société Vaultinum, spécialisée dans la protection et l'audit des logiciels et autres actifs technologiques pour auditer le code source et...
Vaultinum is commissioned by Eurazeo to run a Cyber and Tech Audit
29 mars 2023 08h30 HE
|
Vaultinum
PARIS, March 29, 2023 (GLOBE NEWSWIRE) -- Eurazeo has appointed Vaultinum, a Swiss company specialising in the protection and audit of software and other technology assets, to audit the source code...
Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need
29 mars 2023 08h00 HE
|
Galimedix Therapeutics, Inc.
Galimedix eligible for upfront payment plus various success-based milestone payments and royalties on future net salesEquity investment by Théa Open Innovation into Galimedix supports further...
(XM): Johnson Fistel Investigates Proposed Sale of Qualtrics International; Is $18.15 a Fair Price?
23 mars 2023 19h33 HE
|
Johnson Fistel, LLP
SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Qualtrics International Inc. (Nasdaq:...
Robex Announces the Signing of the US$ 35 Million Bridge Facility With Taurus
21 mars 2023 13h58 HE
|
Robex Resources Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES QUEBEC CITY, March 21, 2023 (GLOBE NEWSWIRE) -- Robex Resources Inc. (TSXV: RBX; FRA: RB4) (“Robex”...
Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
25 janv. 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for Epilepsy Bolsters Presence in Neuroscience Expected to be Accretive in 2023 ...
CryoMass Signs $10.2 Million Multi-State License Agreement
18 janv. 2023 07h10 HE
|
Cryomass Technologies
DENVER, Jan. 18, 2023 (GLOBE NEWSWIRE) -- CryoMass Technologies Inc. (the “Company” or “CryoMass”) (OTCQX: CRYM) is pleased to announce the signing of a multi-state license agreement with...
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
19 déc. 2022 16h10 HE
|
Catalyst Pharmaceuticals, Inc.
Acquisition Expands The Company’s Commercial Portfolio With An Established U.S. Marketed Product Company Remains Dedicated To Growth Within Neurology Through Continued Active Business Development...
Black Friday is Around the Corner: Epomaker Hits the Exciting November Hot-Sale Wave for Mechanical Keyboard Enthusiasts
25 nov. 2022 08h00 HE
|
Epomaker
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Epomaker, the professional customizable mechanical keyboards and accessories provider, launches its Hot-Sale Month campaign for the whole of November in...
vTv Therapeutics Announces Investment by CinRx Pharma
25 juil. 2022 07h00 HE
|
vTv Therapeutics Inc.
HIGH POINT, N.C., July 25, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced entry into agreements that include a $10 million investment by CinPax, LLC (“CinPax”), a...